olanzapine and Eyelid-Diseases

olanzapine has been researched along with Eyelid-Diseases* in 2 studies

Other Studies

2 other study(ies) available for olanzapine and Eyelid-Diseases

Article	Year
Olanzapine-associated bilateral eyelid edema. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delusions; Edema; Eyelid Diseases; Humans; Male; Olanzapine; Psychotic Disorders; Suicide, Attempted	2007
Apraxia of eyelid closure in Huntington's disease. Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:2 We report a patient with genetically confirmed Huntington's disease (HD) presenting apraxia of eyelid closure (AEC). She was unable to close her eyes at command but was able to blink. Chorea and AEC ameliorated significantly during treatment with olanzapine and riluzole, an inhibitor of glutamate release. AEC is reported in progressive supranuclear palsy, Creutzfeldt-Jakob's disease, amyotrophic lateral sclerosis, and as post-stroke AEC. No report on HD is available so far, although oculomotor disturbances are quite common in this disease. Topics: Apraxias; Benzodiazepines; Drug Therapy, Combination; Eyelid Diseases; Female; Humans; Huntington Disease; Middle Aged; Neuroprotective Agents; Olanzapine; Pirenzepine; Riluzole; Selective Serotonin Reuptake Inhibitors	2002

Article

Year

Olanzapine-associated bilateral eyelid edema.

Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2

Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delusions; Edema; Eyelid Diseases; Humans; Male; Olanzapine; Psychotic Disorders; Suicide, Attempted

2007

Apraxia of eyelid closure in Huntington's disease.

Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:2

We report a patient with genetically confirmed Huntington's disease (HD) presenting apraxia of eyelid closure (AEC). She was unable to close her eyes at command but was able to blink. Chorea and AEC ameliorated significantly during treatment with olanzapine and riluzole, an inhibitor of glutamate release. AEC is reported in progressive supranuclear palsy, Creutzfeldt-Jakob's disease, amyotrophic lateral sclerosis, and as post-stroke AEC. No report on HD is available so far, although oculomotor disturbances are quite common in this disease.

Topics: Apraxias; Benzodiazepines; Drug Therapy, Combination; Eyelid Diseases; Female; Humans; Huntington Disease; Middle Aged; Neuroprotective Agents; Olanzapine; Pirenzepine; Riluzole; Selective Serotonin Reuptake Inhibitors

2002